MK 6325

• Description:

  MK 6325 is a HCV NS3/4a protease inhibitor. MK 6325 displays the broad genotype and mutant potency. MK 6325 can be used for the research of infection[1].

• UNSPSC:

  12352005

• Target:

  HCV Protease

• Related Pathways:

  Anti-infection; Metabolic Enzyme/Protease

• Field of Research:

  Infection

• Smiles:

  O=S(NC([C@]1(N2)[C@H](/C=C/CCCCC[C@@](N3)([H])C(N4[C@](C[C@](OC5=NC6=CC(OC)=CC=C6N=C5CCCCC[C@@]7([H])[C@](CCC7)([H])OC3=O)([H])C4)([H])C2=O)=O)C1)=O)(C8(CC8)C)=O

• Molecular Formula:

  C42H56N6O9S

• Molecular Weight:

  820.99

• References & Citations:

  [1]Rudd MT, et al. P2-quinazolinones and bis-macrocycles as new templates for next-generation hepatitis C virus NS3/4a protease inhibitors: discovery of MK-2748 and MK-6325. ChemMedChem. 2015 Apr;10 (4) :727-35.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Reference compound1

• Clinical Information:

  Phase 1

• CAS Number:

  [1263814-52-3]